News | Radiation Oncology | June 05, 2017

Targeted Metastatic Brain Tumor Options

As Metastatic Brain Tumor Rates Rise, Targeted Therapies Offer a Better Treatment Alternative

Gamma Knife

Up to 45 percent of all cancer patients develop brain metastases, tumors that spread to the brain from cancers located elsewhere in the body. As the number of patients affected by metastatic brain tumors grows, targeted treatment options, like the Gamma Knife radiosurgery, may offer better tumor control and symptom management.

Metastatic brain tumors are some of the most common types of tumors that can occur in the brain. As many as 45 percent of all cancer patients develop brain metastases, with an estimated that up to 200,000 people develop metastatic brain tumors each year in the United States. For people with metastatic brain tumors, targeted therapy, like stereotactic radiosurgery using the Gamma Knife at San Diego Gamma Knife Center, offers effective treatment for metastatic brain tumors while helping patients to live as normally as possible.

Metastatic brain tumors, also known as “brain mets,” form when cancerous cells from a tumor located elsewhere in the body, such as in lung or breast, break off from the original, or primary, tumor and travel through the bloodstream. Eventually, these circulating cancer cells cross the blood-brain barrier and settle in the brain(3). Once there, a new brain tumor is formed. Up to 45 percent of cancer patients develop these types of brain tumors.

While it is possible for any type of primary cancer to influence the development of brain mets, some cancers are more likely to cause metastases in the brain than others. As many as 25 percent of patients with lung cancer will develop brain mets. Other forms of cancer, including melanoma and breast, colon, and kidney cancers all frequently promote the formation of brain metastases.

“Since intracranial metastases occur with relatively high frequency and come from common tumors such as, lung cancer and breast cancer, it is important that patients seek effective and appropriate treatment as soon as possible,” said Kenneth Shimizu, M.D., Radiation Oncologist at San Diego Gamma Knife Center.  “Delay and treatment can result in stroke-like symptoms with permanent neurologic damage.”

Traditionally, treatment for brain mets has included invasive surgery to remove tumors or whole brain radiation therapy (WBRT). However, both of these options come with side effects that are often debilitating and, for some types of brain mets, do not significantly increase life expectancy or quality of life for the patient. In many cases, despite efforts to best control the spread of cancerous cells in the brain using these types of treatments, tumors often grow back.

Due, in part, to increased interest in targeted treatment approaches, treatment options like the Gamma Knife are gaining popularity among both healthcare professionals and patients. This advanced radiosurgical system delivers a concentrated dose of radiation directly to metastatic brain tumors. It is minimally invasive, so patients are able to avoid complications associated with traditional surgical interventions. Also, because radiation is not delivered to the entire brain, like with WBRT, patients avoid many of the serious side effects that can occur, including dementia and a decline in physical functioning.

Up to 94 percent of patients who receive treatment using the Gamma Knife are able to achieve therapeutic results, including tumor control. In most cases, this is possible after having just one treatment. This new type of therapy is offered at progressive healthcare facilities nationwide, including the SDGKC.

“Historically, when treating patient with brain metastases, we were only able to use whole brain radiotherapy which would not only treat the metastases but also the normal brain tissue resulting in potential significant side effects, including short-term memory loss,” said Shimizu. He explained that over time, there has been the development of stereotactic radiosurgery (SRS) that targets the tumors and spares the normal brain. With the advent of the Gamma Knife Perfexion unit, targeting has become more precise than at the other treatment platform with less dose to the normal brain. The targeting precision allows treatment of a very high dose with little risk of damage to the normal brain and with more than 90 percent tumor control. 

For more information: www.sdgkc.com

Related Content

Elekta Expands Mosaiq Oncology Information System With PalabraApps
News | Oncology Information Management Systems (OIMS) | April 20, 2018
April 20, 2018 — Elekta announced that it is making a strategic investment in PalabraApps LLC to advance the developm
This image, taken with Canon's Aquilion One, shows a lung with metastases from bowel cancer.

This image, taken with Canon’s Aquilion One, shows a lung with metastases from bowel cancer. Image courtesy of Canon.

Feature | Lung Cancer | April 18, 2018 | Jeff Zagoudis
In recent years, low-dose computed tomography (CT) screening has emerged as a proven, effective method to detect lung
Varian Launches Velocity 4.0 Cancer Imaging Software
Technology | Treatment Planning | April 16, 2018
April 16, 2018 — Varian announced a new version of its Velocity cancer imaging software that includes Rapidsphere, a
First Patient Treated in Online Adaptive Radiotherapy Trial With CyberKnife System
News | Stereotactic Body Radiation Therapy (SBRT) | April 06, 2018
Accuray Inc. and Erasmus MC announced the first patient has been successfully treated using an online-adaptive (OA)...
First Patient Treated on Mevion's S250i Proton Therapy System
News | Proton Therapy | April 05, 2018
Mevion Medical Systems announced the treatment of the first patient in the world on the Mevion S250i Proton Therapy...
ASTRO Updates Guidelines for Palliative Lung Radiation Therapy
News | Radiation Therapy | April 05, 2018
The American Society for Radiation Oncology (ASTRO) issued an update to its clinical guideline for the use of...
Combination Radiotherapy Beneficial in Treating Prostate Cancer
News | Prostate Cancer | March 27, 2018
March 27, 2018 — While there are many treatment options for men with...
Loyola Study Finds Medical Students Receive Little Formal Instruction in Radiation Oncology
News | Radiation Therapy | March 26, 2018
Medical school students receive little formal instruction in radiation oncology, a Loyola study has found.
Overlay Init